GNI Group Ltd. (2160.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

36.4x

EV/EBITDA

−463.3x

Market Cap

JPY 147.16B

MomentumView details →

1D Return

+0.94%

YTD Return

+19.07%

RSI (14)

55.5

ValuationView details →

P/E (Fwd)

36.4x

EV/EBITDA

−463.3x

Market Cap

JPY 147.16B

RSI (14)

55.5

MomentumView details →

1D Return

+0.94%

YTD Return

+19.07%

ProfitabilityView details →

Gross Margin

74.49%

Net Margin

−15.81%

EBITDA Margin

−8.70%

ROE (TTM)

−8.19%

ROA (TTM)

−5.06%

Asset Turnover

0.32x

GrowthView details →

Revenue YoY

+13.68%

EPS YoY

—

FCF YoY

+25.63%

Revenue CAGR 3Y

+15.50%

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.06x

Current Ratio

4.25x

Quick Ratio

3.85x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

27.05B

Net Income (TTM)

−5.84B

Op. CF (TTM)

−2.54B

Next earningsNov 16, 2026 →

Latest newsMore news →

GNI Group completed the acquisition of AYUMI Pharmaceutical.65d ago

GNI Group acquires Ayumi Pharmaceutical Holdings to expand its position as a global biopharmaceutical company.89d ago

Similar companies

KAKEN PHARMACEUTICAL CO.,LTD.4521.T PeptiDream Inc.4587.T KISSEI PHARMACEUTICAL CO.,LTD.4547.T TOWA PHARMACEUTICAL CO.,LTD.4553.T SAWAI GROUP HOLDINGS Co.,Ltd.4887.T Mochida Pharmaceutical Co.,Ltd.4534.T Find similar companies →

Latest newsMore news →

GNI Group completed the acquisition of AYUMI Pharmaceutical.65d ago GNI Group acquires Ayumi Pharmaceutical Holdings to expand its position as a global biopharmaceutical company.89d ago